Share This Article:

Reactivation of Tuberculosis during Dual Therapy with Pegylated Interferon and Ribavirin for Chronic Hepatitis C about a Case

Abstract Full-Text HTML XML Download Download as PDF (Size:456KB) PP. 83-87
DOI: 10.4236/ojgas.2015.57014    2,990 Downloads   3,376 Views  

ABSTRACT

The infection by the virus of the hepatitis C can be associated with other infectious diseases, including the viral and bacterial infections of which the tuberculosis. The infection to Mycobacterium tuberculosis can remain latent during several years and show itself during a state of immunesuppression. The role of the antiviral treatment in the reactivation of the tuberculosis is debated. We bring back an observation of tubercular reactivation during dual therapy with pegylated interferon and ribavirin for a viral chronic hepatitis C. A virologique answer slow was obtained in the 40th week, as well as the reactivation of the tuberculosis. The tuberculosis was of ganglionic localization at our patient. The antituberculous treatment was established while maintaining the treatment. The evolution of the tuberculosis under treatment was favorable but for the VHC, we noted a virologique answer with premature relapse.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Soro, D. , Koné, S. , Ouattara, A. , Ndjitoyap, A. , Okon, A. , Diallo, D. , Assi, C. , Allah, K. , Kouacou, M. and Camara, B. (2015) Reactivation of Tuberculosis during Dual Therapy with Pegylated Interferon and Ribavirin for Chronic Hepatitis C about a Case. Open Journal of Gastroenterology, 5, 83-87. doi: 10.4236/ojgas.2015.57014.

References

[1] El-Serag, H.B., Anand, B., Richardson, P. and Rabeneck, L. (2003) Association between Hepatitis C Infection and Other Infectious Diseases: A Case for Targeted Screening? American Journal of Gastroenterology, 1, 167-174.
http://dx.doi.org/10.1111/j.1572-0241.2003.07176.x
[2] Sudre, P., Ten Dam, G. and Kochi, A. (1992) La tuberculose aujourd'hui dans le monde. Bulletin de l’Organisation mondiale de la Santé, 70, 297-308.
[3] Zignego, A.L., De Carli, M., Monti, M., Careccia, G., La Villa, G., Giannini, C., et al. (1995) Hepatitis C Virus Infection of Mononuclear Cells from Peripheral Blood and Liver Infiltrates in Chronically Infected Patients. Journal of Medical Virology, 47, 58-64.
http://dx.doi.org/10.1002/jmv.1890470112
[4] Ozyilkan, E., Tatar, G., Hacibertasoglu, A., Kayhan, A. and Telatar, H. (1993) Analysis of T-Helper and T-Suppressor Lymphocyte Subsets in Patients with Chronic Hepatitis C Virus Infection. Journal of Internal Medicine, 234, 436-437.
http://dx.doi.org/10.1111/j.1365-2796.1993.tb00773.x
[5] Appelberg, R. (1994) Protective Role of Interferon Gamma, Tumor Necrosis Factor Alpha and Interleukin-6 in Mycobacterium tuberculosis and Mycobacterium avium Infections. Immunobiology, 191, 520-525.
http://dx.doi.org/10.1016/S0171-2985(11)80458-4
[6] Brinkmann, V., Geiger, T., Alkan, S. and Heusser, C.H. (1993) Interferon Alpha Increase the Frequency of Interferon Gamma-Producing Human CD4 T Cells. The Journal of Experimental Medicine, 178, 1655-1663.
http://dx.doi.org/10.1084/jem.178.5.1655
[7] MacQuillan, G.C., Mamotte, C., Reed, W.D., Jeffrey, G.P. and Allan, J.E. (2003) Up Regulation of Endogenous Intrahepatic Interferon Stimulated Genes during Chronic Hepatitis C Virus Infection. Journal of Medical Virology, 70, 219-227.
http://dx.doi.org/10.1002/jmv.10381
[8] Sabbatani, S., Manfred, R., Marinacci, G., Pavoni, M., Cristoni, L. and Chiodo, F. (2005) Reactivation of Severe Acute Pulmonary Tuberculosis during Treatment with Pegylated Interferon-Alpha and Ribavirin for Chronic HCV Hepatitis. Scandinavian Journal of Infectious Diseases, 38, 205-208.
http://dx.doi.org/10.1080/00365540500263268
[9] Farah, R. and Award, J. (2007) The Association of Interferon with the Development of Pulmonary Tuberculosis. International Journal of Clinical Pharmacology and Therapeutics, 45, 598-600.
http://dx.doi.org/10.5414/CPP45598
[10] Belkahla, N., Kchir, H., Maamouri, N., Ouerghi, H., Hariz, F.B., Chouaib, S., Chaabouni, H. and Mami, N.B. (2010) Réactivation d’une tuberculose sous bithérapie interféron-pégylé et ribavirine pour une hépatite chronique C. La Revue de Médecine Interne, 31, e1-e3.
http://dx.doi.org/10.1016/j.revmed.2009.11.017
[11] Van Voccen, J.P. (2010) Diagnostic et traitement de la tuberculose, manuel pratique, recommandations destinées au corps médical. FARES asbl.
[12] Fried, M.W. (2002) Side-Effects of Therapy of Hepatitis C and Their Management. Hepatology, 36, S237-S244.
http://dx.doi.org/10.1002/hep.1840360730
[13] Scanga, C.A., Mohan, V.P., Yu, K., Joseph, H., Tanaka, H., Chan, J., et al. (2000) Depletion of CD4+ T-Cells Causes Reactivation of Murine Persistant Tuberculosis Despite Continued Expression of Interferon Gamma and Nitric Oxide Synthetase 2. The Journal of Experimental Medicine, 192, 347-358.
http://dx.doi.org/10.1084/jem.192.3.347
[14] Nahon, P., Brugière, O., Marcellin, P. and Valla, D. (2004) Role protecteur accidentel de l’interféron alpha contre Mycobacterium tuberculosis au cours d’un traitement anti viral C. Gastroentérologie Clinique et Biologique, 28, 609-618.
http://dx.doi.org/10.1016/S0399-8320(04)95020-8

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.